Pediatrix Medical Group, Inc. (MD) on Decifer

Decifer ranks MD number 147 of 277 tracked names on durable business quality.

Why it ranks here

• It earns solid returns on the money it puts to work, around 10% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is expected to grow about 2% a year, profits grew 263% over the past year, and growth is speeding up, not slowing down.
• It keeps a thin share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power.
• and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.
• Profits grew 263% and returns near 10% show a good business, but expected revenue growth of only about 2%, momentum of 20 out of 35, and no funded role leave no clear reason to grow.

The current read

The evidence on MD lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Care Delivery & Ageing Services: The population needing daily care is growing faster than the clinical workforce serving it, and payers are moving that care to the cheapest adequate setting, which shifts volume from hospitals to home and post-acute operators.

Read the full MD research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.